Premium
ANTI‐AMYLASE, ANTI‐GLUCOSIDASE AND ANTI‐ANGIOTENSIN I‐CONVERTING ENZYME POTENTIAL OF SELECTED FOODS
Author(s) -
MCCUE PATRICK,
KWON YOUNGIN,
SHETTY KALIDAS
Publication year - 2005
Publication title -
journal of food biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.507
H-Index - 47
eISSN - 1745-4514
pISSN - 0145-8884
DOI - 10.1111/j.1745-4514.2005.00020.x
Subject(s) - amylase , postprandial , chemistry , food science , phytochemical , enzyme , antioxidant , glycemic , meal , diabetes mellitus , biochemistry , traditional medicine , medicine , endocrinology
α‐Amylase and α‐glucosidase have been targeted as potential avenues for modulation of postprandial hyperglycemia through mild inhibition of the enzymatic breakdown of complex carbohydrates to decrease meal‐derived glucose absorption. Water‐soluble extracts with optimized phenolic content of selected American and Asian foods were investigated for inhibitory activity against α‐amylase and α‐glucosidase, as well as angiotensin I‐converting enzyme (ACE), which has been linked to hyperglycemia‐associated hypertension. Porcine pancreatic α‐amylase (PPA) was allowed to react with each phenolic‐optimized food extract, and the derivatized enzyme–phytochemical mixtures obtained were characterized for residual amylase activity. The α‐glucosidase and ACE activities were determined in the presence of each phenolic‐optimized food extract. The amylase activity was inhibited more than the glucosidase activity in the presence of these phytochemical extracts, and more so by Asian foods than by American foods. The Asian spice ginger was found to possess strong ACE inhibitory activity in addition to significant anti‐amylase activity. The α‐amylase enzyme inhibition was positively associated with extract antioxidant activity and negatively with extract protein content. The significance of food‐grade, plant‐based amylase inhibitors for modulation of carbohydrate breakdown and control of glycemic index of foods in the context of preventing hyperglycemia and diabetes mellitus complications in the long term and ACE inhibitors for modulation of associated hypertension is hypothesized and discussed.